A subset of tumor‐associated HLA‐DR+ neutrophils was also identified in early‐stage human lung cancer tumor tissue, which can cross‐present antigens to CD8+ T cells, triggering antitumor T cell immune responses.313. The gene discussed is CD8A; the disease is neoplasm.